Small Molecules
23 December 2014
BioCryst Announces Study Results for BCX4430 in a Non-Human Primate Model of Ebola Virus Infection23 December 2014
PTC Therapeutics Begins Rolling NDA Submission to the FDA for Translarna to Treat Duchenne Muscular Dystrophy23 December 2014
Mirati Therapeutics Doses First Patient in Expansion Cohorts of Phase 1b Trial of MGCD265 in Genetically Selected Patients23 December 2014
Actelion submits US FDA New Drug Application for selexipag (Uptravi) in patients with pulmonary arterial hypertension22 December 2014
GSK announces US regulatory submission seeking additional indication for eltrombopag (Promacta™)22 December 2014
BioCryst’s RAPIVAB(TM) (peramivir injection) Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza22 December 2014
MIV-802 has been selected as a candidate drug and enters non-clinical development for the treatment of hepatitis C infection20 December 2014
LYNPARZA™ approved by the US food and drug administration for the treatment of advanced ovarian cancer in patients with germline BRCA-mutations19 December 2014
RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second Phase 2 Clinical Compound19 December 2014
FDA Accepts IND Application for Radius Health’s Investigational Drug RAD1901 Being Developed for Potential Use in Metastatic Breast Cancer19 December 2014
CHMP recommends Approval of XadagoTM (safinamide) to treat Parkinson´s disease in the EU19 December 2014
Vernalis plc: Update on AUY922 Development Programme19 December 2014
Galapagos initiates first Phase 1 study in cystic fibrosis and will receive milestone payment from AbbVie18 December 2014
TetraLogic Announces Initiation of a Randomized Phase 2 Clinical Trial of SHAPE in Subjects With Cutaneous T-Cell Lymphoma18 December 2014
Curis Announces Dosing of First Patient in Phase 1 Trial of CUDC-907 in Patients With Advanced/ Relapsed Solid Tumors18 December 2014
BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary AngioedemaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports